These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11085343)

  • 1. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs.
    Koh HL; Woo SO
    Drug Saf; 2000 Nov; 23(5):351-62. PubMed ID: 11085343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory control of Chinese Proprietary Medicines in Singapore.
    Yee SK; Chu SS; Xu YM; Choo PL
    Health Policy; 2005 Feb; 71(2):133-49. PubMed ID: 15607377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A U.S. perspective on the adverse reactions from traditional Chinese medicines.
    Ko RJ
    J Chin Med Assoc; 2004 Mar; 67(3):109-16. PubMed ID: 15181962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic heavy metals and undeclared drugs in Asian herbal medicines.
    Ernst E
    Trends Pharmacol Sci; 2002 Mar; 23(3):136-9. PubMed ID: 11879681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined DNA, toxicological and heavy metal analyses provides an auditing toolkit to improve pharmacovigilance of traditional Chinese medicine (TCM).
    Coghlan ML; Maker G; Crighton E; Haile J; Murray DC; White NE; Byard RW; Bellgard MI; Mullaney I; Trengove R; Allcock RJ; Nash C; Hoban C; Jarrett K; Edwards R; Musgrave IF; Bunce M
    Sci Rep; 2015 Dec; 5():17475. PubMed ID: 26658160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status and development of monitoring on adverse reaction of traditional Chinese medicine in China].
    Zhang L; Yang XH; Cao LY; Ji S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):581-4. PubMed ID: 16089130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usage and adverse effects of Chinese herbal medicines.
    Chan TY; Critchley JA
    Hum Exp Toxicol; 1996 Jan; 15(1):5-12. PubMed ID: 8845209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese herbal medicines revisited: a Hong Kong perspective.
    Chan TY; Chan JC; Tomlinson B; Critchley JA
    Lancet; 1993 Dec 18-25; 342(8886-8887):1532-4. PubMed ID: 7902907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine - A Retrospective Analysis.
    Melchart D; Hager S; Dai J; Weidenhammer W
    Forsch Komplementmed; 2016; 23 Suppl 2():21-8. PubMed ID: 27272353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.
    Cheng CW; Bian ZX; Li YP; Moher D; Wu TX; Dagenais S; Li J; Li TQ
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):881-6. PubMed ID: 18782527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC and GC-MS screening of Chinese proprietary medicine for undeclared therapeutic substances.
    Liu SY; Woo SO; Koh HL
    J Pharm Biomed Anal; 2001 Mar; 24(5-6):983-92. PubMed ID: 11248492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of complementary therapies: an eastern perspective.
    Tomlinson B; Chan TY; Chan JC; Critchley JA; But PP
    J Clin Pharmacol; 2000 May; 40(5):451-6. PubMed ID: 10806596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines.
    Kim EJ; Chen Y; Huang JQ; Li KM; Razmovski-Naumovski V; Poon J; Chan K; Roufogalis BD; McLachlan AJ; Mo SL; Yang D; Yao M; Liu Z; Liu J; Li GQ
    J Ethnopharmacol; 2013 Mar; 146(1):40-61. PubMed ID: 23286904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicities by herbal medicines with emphasis to traditional Chinese medicine.
    Efferth T; Kaina B
    Curr Drug Metab; 2011 Dec; 12(10):989-96. PubMed ID: 21892916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events associated with metal contamination of traditional chinese medicines in Korea: a clinical review.
    Kim H; Hughes PJ; Hawes EM
    Yonsei Med J; 2014 Sep; 55(5):1177-86. PubMed ID: 25048473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Chinese herbal medicine and anaesthesia.
    Kam PC; Liew S
    Anaesthesia; 2002 Nov; 57(11):1083-9. PubMed ID: 12392455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adulteration of proprietary Chinese medicines and health products with undeclared drugs: experience of a tertiary toxicology laboratory in Hong Kong.
    Ching CK; Chen SPL; Lee HHC; Lam YH; Ng SW; Chen ML; Tang MHY; Chan SSS; Ng CWY; Cheung JWL; Chan TYC; Lau NKC; Chong YK; Mak TWL
    Br J Clin Pharmacol; 2018 Jan; 84(1):172-178. PubMed ID: 28965348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of Chinese herbal pieces and analysis of problems of total quality management].
    Wang J; Qiao XY; Lin F; Chen YF
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4475-8. PubMed ID: 25850288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.